The immunogenicity and tolerability of hepatitis A virus vaccine was evaluated in a group of 32 children with human immunodeficiency virus (HIV) infection and 27 children with seroreversion. After 2 doses of vaccine, 100% of children experienced seroconversion with good toleration of the vaccine. There were no differences in variation of virus load between immunized HIV-positive children and a group of 31 nonimmunized HIV-positive children with similar characteristics.Universidade Federal de São Paulo, Div Pediat Infect Dis, São Paulo, BrazilUniversidade Federal de São Paulo, Div Pediat Infect Dis, São Paulo, BrazilWeb of Scienc
Hepatitis A vaccination has been recommended to patients with hemophilia since they are exposed to p...
Abstract Background Since its development in the early 1980s, Hepatitis B virus (HBV) vaccine has be...
Background: Hepatitis C virus (HCV) is a major public health problem for Human Immunodeficiency viru...
Vaccination in HIV-infected children is often less effective than in healthy children. The goal of t...
Background: HIV-exposed uninfected (HEU) children have increased risk of infectious morbidity during...
Objetivo - Avaliar a prevalencia de anticorpos contra o HAV em criancas e adolescentes expostos e /o...
Human Immunodeficiency Virus (HIV) infected children have a 30–70% chance of being incompletely immu...
Objetivo: Avaliar a persistencia dos anticorpos contra o virus da hepatite A (VHA) sete anos apos a ...
Background. Human immunodeficiency virus (HIV)–infected patients have weak responses to vaccines and...
Humoral immune response to vaccine antigens is known to be reduced in perinatally HIV-infected child...
BACKGROUND: HIV-infected children have a lower seroconversion rate to hepatitis B virus (HBV) immuni...
Human Immunodeficiency Virus (HIV) infected children have a 30–70% chance of being incompletely immu...
OBJETIVO: Avaliar a prevalência de anticorpos contra o vírus da hepatite A em crianças e adolescente...
Prevalence of Human-Immunodeficiency-Virus/Hepatitis-B-virus (HIV/HBV) coinfection and HBV vaccinati...
OBJECTIVE: To assess possible factors associated with the loss of antibodies to hepatitis A 7 years ...
Hepatitis A vaccination has been recommended to patients with hemophilia since they are exposed to p...
Abstract Background Since its development in the early 1980s, Hepatitis B virus (HBV) vaccine has be...
Background: Hepatitis C virus (HCV) is a major public health problem for Human Immunodeficiency viru...
Vaccination in HIV-infected children is often less effective than in healthy children. The goal of t...
Background: HIV-exposed uninfected (HEU) children have increased risk of infectious morbidity during...
Objetivo - Avaliar a prevalencia de anticorpos contra o HAV em criancas e adolescentes expostos e /o...
Human Immunodeficiency Virus (HIV) infected children have a 30–70% chance of being incompletely immu...
Objetivo: Avaliar a persistencia dos anticorpos contra o virus da hepatite A (VHA) sete anos apos a ...
Background. Human immunodeficiency virus (HIV)–infected patients have weak responses to vaccines and...
Humoral immune response to vaccine antigens is known to be reduced in perinatally HIV-infected child...
BACKGROUND: HIV-infected children have a lower seroconversion rate to hepatitis B virus (HBV) immuni...
Human Immunodeficiency Virus (HIV) infected children have a 30–70% chance of being incompletely immu...
OBJETIVO: Avaliar a prevalência de anticorpos contra o vírus da hepatite A em crianças e adolescente...
Prevalence of Human-Immunodeficiency-Virus/Hepatitis-B-virus (HIV/HBV) coinfection and HBV vaccinati...
OBJECTIVE: To assess possible factors associated with the loss of antibodies to hepatitis A 7 years ...
Hepatitis A vaccination has been recommended to patients with hemophilia since they are exposed to p...
Abstract Background Since its development in the early 1980s, Hepatitis B virus (HBV) vaccine has be...
Background: Hepatitis C virus (HCV) is a major public health problem for Human Immunodeficiency viru...